Biocryst Pharmaceuticals Inc
BCRXNasdaqCIK 882796HealthcareFiscal year ends Dec 31
Reports and events: 424 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053300 |
| 2026-08-0507:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005223 |
| 2026-08-0407:01 ET | 8-K/A | 2.05 Exit or disposal costs | 0001171843-26-005168 |
| 2026-06-2907:06 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004333 |
| 2026-06-1216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-004096 |
| 2026-05-0616:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031238 |
| 2026-05-0607:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003052 |
| 2026-05-0407:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002960 |
| 2026-04-2316:02 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001628280-26-026822 |
| 2026-02-2616:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012240 |
| 2026-02-2607:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001119 |
| 2026-01-2316:32 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001171843-26-000405 |
| 2026-01-2316:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002200 |
| 2026-01-1216:28 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000213 |
| 2026-01-0907:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001171843-26-000154 |
| 2025-12-1207:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007909 |
| 2025-12-1107:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-007878 |
| 2025-12-0308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-044110 |
| 2025-11-0416:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048785 |
| 2025-11-0307:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-006881 |
| 2025-10-1407:10 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-038031 |
| 2025-10-0108:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-036875 |
| 2025-08-1107:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-005265 |
| 2025-08-0516:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037795 |
| 2025-08-0407:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004977 |
| 2025-07-3107:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004869 |
| 2025-07-0707:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004324 |
| 2025-06-3007:37 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-024089 |
| 2025-06-2707:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004186 |
| 2025-06-2506:57 ET | 8-K | 8.01 Other events | 0001171843-25-004091 |
| 2025-06-1616:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-003910 |
| 2025-06-0407:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-003662 |
| 2025-05-1407:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-003152 |
| 2025-05-0616:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022658 |
| 2025-05-0507:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002739 |
| 2025-05-0107:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-002669 |
| 2025-04-2416:03 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001628280-25-019659 |
| 2025-04-1016:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-002147 |
| 2025-03-1106:26 ET | 8-K | 8.01 Other events | 0001171843-25-001383 |
| 2025-03-0408:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-001231 |
| 2025-02-2516:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007715 |
| 2025-02-2407:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001020 |
| 2025-01-1307:09 ET | 8-K | 7.01 Regulation FD disclosure | 0001171843-25-000190 |
| 2025-01-1007:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-000155 |
| 2025-01-0807:20 ET | 8-K | 7.01 Regulation FD disclosure | 0001171843-25-000112 |
| 2024-11-0517:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045364 |
| 2024-11-0407:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005975 |
| 2024-10-0207:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005439 |
| 2024-09-3007:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-005393 |
| 2024-08-0616:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035170 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.